Polymorphism in factor VII gene modifies phenotype of severe haemophilia

Haemophilia

Volumn 15, Issue 6, 2009, Pages 1228-1236

  Jayandharan, G R ^a   Nair, S C ^a   Poonnoose, P M ^a   Thomas, R ^a   John, J ^a   Keshav, S K ^b   Cherian, R S ^b   Devadarishini, M ^a   Lakshmi, K M ^a   Shaji, R V ^a   Viswabandya, A ^a   George, B ^a   Mathews, V ^a   Chandy, M ^a   Srivastava, A ^a  

^a Department of Haematology ^*  (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Haemophilia; Phenotype; Polymorphism; Variation

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR CONCENTRATE; GLUTAMINE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DNA POLYMORPHISM; GENE MUTATION; GENOTYPE; HEMARTHROSIS; HEMOPHILIA; HUMAN; IMMUNOREGULATION; INCIDENCE; INFLAMMATION; JOINT FUNCTION; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; THROMBOSIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; CHILD; CHILD, PRESCHOOL; FACTOR VII; GENETIC ASSOCIATION STUDIES; GENOTYPE; HEMOPHILIA A; HEMOPHILIA B; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 70449706305     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02080.x     Document Type: Article

References (34)

1. Schramm W, Royal S, Kroner B. Clinical outcomes and resource utilization associated with haemophilia care in Europe. Haemophilia 2002, 8:33-43.
2. Molho P, Rolland N, Lebrun T. Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. The French Study Group. Haemophilia 2000, 6:23-32. E-mail:
3. Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994, 236:391-9.
4. Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet 2003, 361:1801-9.
5. Pollmann H, Richter H, Ringkamp H, Jurgens H. When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP study. Eur J Pediatr 1999, 158(Suppl. 3):S166-70.
6. Ramgren O. Haemophilia in Sweden. III. Symptomatology, with special reference to differences between haemophilia A and B. Acta Med Scand 1962, 171:237-42.
7. Rainsford SG, Hall A. A three-year study of adolescent boys suffering from haemophilia and allied disorders. Br J Haematol 1973, 24:539-51.
8. Blanchette P, Rivard G, Israels S. A survey of factor prophylaxis in the Canadian haemophilia A population. Haemophilia 2004, 10:679-83.
9. Beltran-Miranda CP, Khan A, Jaloma-Cruz AR, Laffan MA. Thrombin generation and phenotypic correlation in haemophilia A. Haemophilia 2005, 11:326-34.
10. Shima M, Matsumoto T, Fukuda K. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C). Thromb Haemost 2002, 87:436-41.
11. van Dijk K, van der Bom JG, Lenting PJ. Factor VIII half-life and clinical phenotype of severe hemophilia A. Haematologica 2005, 90:494-8.
12. Arbini AA, Mannucci PM, Bauer KA. Low prevalence of the factor V Leiden mutation among " severe" hemophiliacs with a " milder" bleeding diathesis. Thromb Haemost 1995, 74:1255-8.
13. Escuriola Ettingshausen C, Halimeh S, Kurnik K. Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors. Thromb Haemost 2001, 85:218-20.
14. Ghosh K, Shetty S, Mohanty D. Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one-stage assay. Haemophilia 2001, 7:9-12.
15. van Dijk K, van der Bom JG, Fischer K, Grobbee DE, van den Berg HM. Do prothrombotic factors influence clinical phenotype of severe haemophilia? A review of the literature. Thromb Haemost 2004, 92:305-10.
16. Jayandharan G, Srivastava A. The phenotypic heterogeneity of severe hemophilia. Semin Thromb Haemost 2008, 34:128-41.
17. Rodriguez-Merchan EC, de la Corte H, Rodriguez-Merchan EC. Musculoskeletal outcomes research in haemophilia. The Haemophilic Joints New Perspectives 2003, 36-44. In, ed, Chapter 7, Oxford, Blackwell Publishing
18. Pettersson H, Ahlberg A, Nilsson IM. A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res 1980, 149:153-9.
19. Poonnoose PM, Manigandan C, Thomas R. Functional independence score in haemophilia: a new performance-based instrument to measure disability. Haemophilia 2005, 11:598-602.
20. Kasper CK, Aledort L, Aronson D. Proceedings: a more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975, 34:612.
21. Lattuada A, Preda L, Sacchi E, Gallo L, Federici AB, Rossi E. A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000). Blood Coagul Fibrinolysis 2004, 15:505-11.
22. Nair SC, Mammen J, Srivastava A, Singh S, Kavitha ML, Vishwabandya A. Clot curve analysis - another method to assess coagulation using photo-optical data: clinical application and comparison with thrombin generation test. Haemophilia 2004, 10(Suppl. 3):S13.
23. Nair S, Sakthivel MSM, Mammen JJ. Data from APTT clot curves of automated photo-optical coagulometers correlates better with heterogeneity of clinical presentation in severe hemophilia a than FVIII:C levels. J Thromb Haemost 2005, 3:1740-3340.
24. Jayandharan G, Shaji RV, Baidya S, Nair SC, Chandy M, Srivastava A. Identification of factor VIII gene mutations in 101 patients with haemophilia A: mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modelling of 10 novel missense substitutions. Haemophilia 2005, 11:481-91.
25. Jayandharan G, Shaji RV, Chandy M, Srivastava A. Identification of factor IX gene defects using a multiplex PCR and CSGE strategy - a first report. J Thromb Haemost 2003, 1:2051-4.
26. Goodeve AC, Peake IR. The molecular basis of hemophilia A: genotype-phenotype relationships and inhibitor development. Semin Thromb Hemost 2003, 29:23-30.
27. van Dijk K, Fischer K, van der Bom JG, Grobbee DE, van den Berg HM. Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed. Haemophilia 2005, 11:438-43.
28. Grunewald M, Siegemund A, Grunewald A, Konegan A, Koksch M, Griesshammer M. Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia. Haemophilia 2002, 8:768-75.
29. Shetty S, Vora S, Kulkarni B. Contribution of natural anticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients. Br J Haematol 2007, 138:541-4.
30. van Dijk K. Explaining Variation in Bleeding Pattern of Severe Haemophilia 2004, PhD Thesis, Utrecht, University of Utrecht
31. Shima M. The application of waveform analysis in hemophilia. Haemophilia 2004, 10(Suppl. 3):S11.
32. Di Castelnuovo A, D'Orazio A, Amore C. Genetic modulation of coagulation factor VII plasma levels: contribution of different polymorphisms and gender-related effects. Thromb Haemost 1998, 80:592-7.
33. Iacoviello L, Di Castelnuovo A, De Knijff P, D'Orazio A. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998, 338:79-85.
34. Bottema CD, Ketterling RP, Ii S, Yoon HS, Phillips JA, Sommer SS. Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as " spacer" elements. Am J Hum Genet 1991, 49:820-38.